News
In a major policy change, the Food and Drug Administration has announced a plan to limit access to future COVID-19 shots only ...
The FDA warns that longtime users of popular allergy medications may experience "severe itching" after stopping use.
The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
FDA FLAGS SEVERE ITCH — Patients who stop using the oral allergy medicines cetirizine (Zyrtec) or levocetirizine (Xyzal) may ...
The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
The agency will require manufacturers to add a warning to prescription and OTC labeling about the risk of itching and the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results